CORC

浏览/检索结果: 共10条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-alpha 2a: 1 year follow-up of the OSST study 期刊论文
Antiviral therapy, 2016, 卷号: 21, 期号: 4, 页码: 337-344
作者:  Han, Meifang;  Jiang, Jiaji;  Hou, Jinlin;  Tan, Deming;  Sun, Yongtao
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result 期刊论文
Clinical and Experimental Medicine, 2016, 卷号: 16, 期号: 3, 页码: 429-436
作者:  Cai, Shaohang;  Yu, Tao;  Jiang, Yegui;  Zhang, Yonghong;  Lv, Fangfang
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/03
A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection. 期刊论文
The Journal of Clinical Pharmacology, 2015, 卷号: 55, 期号: 3, 页码: 288-297
作者:  Zuo, Shan-Ru;  Zuo, Xiao-Cong;  Wang, Chun-Jiang;  Ma, Yu-Tao;  Zhang, Hao-Ye
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/03
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial) 期刊论文
Journal of Hepatology, 2014, 卷号: 61, 期号: 4, 页码: 777-784
作者:  Ning, Qin*;  Han, Meifang;  Sun, Yongtao;  Jiang, Jiaji;  Tan, Deming
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/03
Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis 期刊论文
Clinical Therapeutics, 2013, 卷号: 35, 期号: 12, 页码: 1997-2006
作者:  Huang, Ze-Bing;  Zhao, Shu-Shan;  Huang, Yan;  Dai, Xia-Hong;  Zhou, Rong-Rong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a ‘real‐world’ clinical practice setting in China 期刊论文
Journal of Viral Hepatitis, 2013, 卷号: 20, 期号: 11, 页码: 811-820
作者:  Hou, J. -L*;  Jia, J. -D.;  Wei, L.;  Zhao, W.;  Wang, Y. M.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review 期刊论文
Virology Journal, 2010, 卷号: 7, 期号: 1, 页码: 211
作者:  Zhao, Shushan*;  Tang, Lanhua;  Fan, Xuegong;  Chen, Lizhang;  Zhou, Rongrong
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/03
Short-term entecavir therapy of chronic severe hepatitis B 期刊论文
Hepatobiliary & pancreatic diseases international : HBPD INT, 2009, 卷号: 8, 期号: 3, 页码: 261-266
作者:  Chen, Jun;  Han, Jian-Hua;  Liu, Chun;  Yu, Ren-He;  Li, Fa-Zhao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/03
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naive Chinese patients with chronic hepatitis B: a randomized, multicenter study. 期刊论文
Hepatology International, 2008, 卷号: 2, 期号: 4, 页码: 486-493
作者:  Yao, Guangbi*;  Chen, ChengWei;  Lu, WeiLun;  Ren, Hong;  Tan, DeMing
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naive patients with chronic hepatitis B: a randomized double-blind trial in China. 期刊论文
HEPATOLOGY INTERNATIONAL, 2007, 卷号: 1, 期号: 3, 页码: 365-372
作者:  Guangbi Yao;  Chengwei Chen;  Weilun Lu;  Hong Ren;  Deming Tan
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace